Sunil Kumar Ahuja Explained

Sunil K. Ahuja
Birth Date:13 March 1961
Fields:Genetics, immunology, molecular biology

Sunil Kumar Ahuja (born March 13, 1961)[1] is a professor of Medicine, Microbiology, Immunology & Biochemistry at the University of Texas Health Science Center at San Antonio and an expert on the role of immunogenetics on HIV pathogenesis. Ahuja is also the Director of the Veterans Administration Research Center for AIDS and HIV-1 Infection. His most recent work, first published in the 2005 issue of Science, involves the ethnic group-specific role of CCR5 haplotype and CCL3L1 gene copy number on the progression of HIV to AIDS.[2]

Education

Sunil Ahuja received his medical degree from the Armed Forces Medical College India in 1983.[3] Following work towards a M.Sc. degree from the University of Alberta in Canada, Ahuja had his internship and residency at the SUNY Health Science Center at Brooklyn.

Publications

Sunil Ahuja's research has been published in many peer-reviewed journals, including Science, The New England Journal of Medicine, Nature Medicine, Nature Immunology and Proceedings of the National Academy of Sciences.

Honors

Ahuja has been the recipient of many honors and awards, including being named in 2001 the Elizabeth Glaser Scientist and the Burroughs Wellcome Clinical Scientist in Translational Research.[4] [5] In 2005 he also was the recipient of the MERIT award from the National Institutes of Health. Less than 5% of NIH-funded researchers receive this award.[5]

In February 2008, Ahuja was listed as one of "35 People Who Will Shape Our Future" by Texas Monthly magazine.[3]

Scientific disagreements

Some of Sunil Ahuja's work has been questioned by the scientific community. In July 2008, Ahuja's group reported that the DARC gene influenced HIV/AIDS susceptibility.[6] This finding was then questioned by four other groups of scientists, reporting the failure to replicate.[7] [8] [9] [10] Ahuja's group responded in the same issue of Cell Host & Microbe,[11] and also in a subsequent study published in 2011.[12]

External links

Notes and References

  1. Web site: Dr. Ahuja, Sunil K, MD . 2008-05-07 . dead . https://archive.today/20120905233700/http://www.mdjunction.com/doctor/sunil-kumar-ahuja/20623 . 2012-09-05 .
  2. The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility. Enrique. Gonzalez. Hemant. Kulkarni. Hector. Bolivar. Andrea. Mangano. Racquel. Sanchez. Gabriel. Catano. Robert J.. Nibbs. Barry I.. Freedman. Marlon P.. Quinones. Michael J.. Bamshad. Krishna K.. Murthy. Brad H.. Rovin. William. Bradley. Robert A.. Clark. Stephanie A.. Anderson. Robert J.. O'Connell. Brian K.. Agan. Seema S.. Ahuja. Rosa. Bologna. Luisa. Sen. Matthew J.. Dolan. Sunil K.. Ahuja. 6 January 2005. Science. 307. 5714. 1434–1440. 10.1126/science.1101160. 15637236. 2005Sci...307.1434G. 8815153.
  3. Web site: Sunil K. Ahuja: Texas Monthly February 2008 . 2008-04-12 . dead . https://web.archive.org/web/20080704205650/http://www.texasmonthly.com/2008-02-01/feature9.php . 2008-07-04 .
  4. Web site: Awards. www.uthscsa.edu. 12 August 2017. 17 June 2004. https://web.archive.org/web/20040617034219/http://www.uthscsa.edu/opa/issues/new34-2/ahuja.html. dead.
  5. Web site: News - UT Health Science Center San Antonio - UT Health Science Center News. UT Health Science Center News. 12 August 2017.
  6. Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility. He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK . Cell Host Microbe . 2008 . 4. 52–62 . 18621010 . 10.1016/j.chom.2008.06.002. 1. 2562426.
  7. The Duffy Antigen Receptor for Chemokines Null Promoter Variant Does Not Influence HIV-1 Acquisition Or Disease Progression . Walley NM, Julg B, Dickson SP, etal . Cell Host Microbe . 2009 . 5. 408–410 . 19454339 . 10.1016/j.chom.2009.04.011. 5. 2720554.
  8. Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans. Winkler CA, An P, Johnson R, Nelson GW, Kirk G . Cell Host Microbe . 2009 . 5. 411–413 . 19454340 . 10.1016/j.chom.2009.04.010. 5. 7241868 .
  9. Lack of Duffy Antigen Receptor for Chemokines: No Influence on HIV Disease Progression in an African Treatment Naïve Population . Julg B, Reddy S, van der Stok M, etal . Cell Host Microbe . 2009 . 5. 413–415 . 19454341 . 10.1016/j.chom.2009.04.009. 5. 2749504.
  10. Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort . Horne KC, Li X, Jacobson LP, etal . Cell Host Microbe . 2009 . 5. 415–417 . 19454342 . 10.1016/j.chom.2009.04.013. 5. free .
  11. Author reply. Cell Host Microbe . 2009 . 5. 5 . 418–419 . 10.1016/j.chom.2009.05.007. He . Weijing . Marconi . Vincent C. . Castiblanco . John . Kulkarni . Hemant . Clark . Robert A. . Dolan . Matthew J. . Weiss . Robin A. . Ahuja . Sunil K. . free .
  12. Ramsuran . V . Kulkarni . H . He . W . Mlisana . K . Wright . EJ . Werner . L . Castiblanco . J . Dhanda . R . Le . T . Dolan . MJ . Guan . W . Weiss . RA . Clark . RA . Karim . SS . Ahuja . SK . Ndung'u . T . Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. . Clinical Infectious Diseases . May 2011 . 52 . 10 . 1248–56 . 10.1093/cid/cir119 . 21507922 . 3115278.